{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:12:35Z","timestamp":1724112755789},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,18]]},"DOI":"10.7759\/cureus.67162","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T06:53:57Z","timestamp":1724050437000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Changes in Cardiac Troponin I Levels After Direct Current Cardioversion in Patients With Atrial Fibrillation"],"prefix":"10.7759","author":[{"given":"Marina","family":"Katerini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Politi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olympia","family":"Konstantakopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Kyritsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgenia","family":"Minasidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambrini","family":"Kourkouta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Koukourikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areti","family":"Tsaloglidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.102181","article-title":"Atrial fibrillation and stroke: state-of-the-art and future directions","volume":"49","author":"Elsheikh S","year":"2024","unstructured":"Elsheikh S, Hill A, Irving G, Lip GY, Abdul-Rahim AH. Atrial fibrillation and stroke: state-of-the-art and future directions. Curr Probl Cardiol. 2024, 49:102181. 10.1016\/j.cpcardiol.2023.102181","journal-title":"Curr Probl Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study","volume":"129","author":"Chugh SS","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, et al.. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study. Circulation. 2014, 129:837-47. 10.1161\/CIRCULATIONAHA.113.005119","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi G","year":"2021","unstructured":"Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021, 16:217-21. 10.1177\/1747493019897870","journal-title":"Int J Stroke"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof P","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, et al.. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016, 18:1609-78. 10.1093\/europace\/euw295","journal-title":"Europace"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19084880","article-title":"Pharmacological cardioversion in patients with recent-onset atrial fibrillation and chronic kidney disease subanalysis of the CANT II study","volume":"19","author":"Ceynowa-Sielawko B","year":"2022","unstructured":"Ceynowa-Sielawko B, Wybraniec MT, Topp-Zieli\u0144ska A, et al.. Pharmacological cardioversion in patients with recent-onset atrial fibrillation and chronic kidney disease subanalysis of the CANT II study. Int J Environ Res Public Health. 2022, 19:4880. 10.3390\/ijerph19084880","journal-title":"Int J Environ Res Public Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaa057","article-title":"Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure","volume":"22","author":"Brandes A","year":"2020","unstructured":"Brandes A, Crijns HJ, Rienstra M, Kirchhof P, Grove EL, Pedersen KB, Van Gelder IC. Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure. Europace. 2020, 22:1149-61. 10.1093\/europace\/euaa057","journal-title":"Europace"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051029","article-title":"Pharmacological cardioversion after pre-treatment with antiarrythmic drugs prior to electrical cardioversion in persistent atrial fibrillation: impact on maintenance of sinus rhythm","volume":"10","author":"El Amrani A","year":"2021","unstructured":"El Amrani A, Vi\u00f1olas X, Arias MA, Bazan V, Valdovinos P, Alegret JM. Pharmacological cardioversion after pre-treatment with antiarrythmic drugs prior to electrical cardioversion in persistent atrial fibrillation: impact on maintenance of sinus rhythm. J Clin Med. 2021, 10:1029. 10.3390\/jcm10051029","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.01.099","article-title":"Contemporary real life cardioversion of atrial fibrillation: results from the multinational RHYTHM-AF study","volume":"172","author":"Crijns HJ","year":"2014","unstructured":"Crijns HJ, Weijs B, Fairley AM, et al.. Contemporary real life cardioversion of atrial fibrillation: results from the multinational RHYTHM-AF study. Int J Cardiol. 2014, 172:588-94. 10.1016\/j.ijcard.2014.01.099","journal-title":"Int J Cardiol"},{"key":"ref10","unstructured":"Direct current (DC) cardioversion-defibrillation. (2023). https.\/\/www.msdmanuals.com\/en-in\/professional\/cardiovascular-disorders\/overview-of-arrhythmias-and-conduction-disorde...."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.04.089","article-title":"Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study","volume":"62","author":"Airaksinen KE","year":"2013","unstructured":"Airaksinen KE, Gr\u00f6nberg T, Nuotio I, Nikkinen M, Ylitalo A, Biancari F, Hartikainen JE. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study. J Am Coll Cardiol. 2013, 62:1187-92. 10.1016\/j.jacc.2013.04.089","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut143","article-title":"Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey","volume":"15","author":"Hern\u00e1ndez-Madrid A","year":"2013","unstructured":"Hern\u00e1ndez-Madrid A, Svendsen JH, Lip GY, Van Gelder IC, Dobreanu D, Blomstrom-Lundqvist C. Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey. Europace. 2013, 15:915-8. 10.1093\/europace\/eut143","journal-title":"Europace"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.19102\/icrm.2023.14101","article-title":"The role of biochemical cardiac markers in atrial fibrillation","volume":"14","author":"Rafaqat S","year":"2023","unstructured":"Rafaqat S, Rafaqat S, Ijaz H. The role of biochemical cardiac markers in atrial fibrillation. J Innov Card Rhythm Manag. 2023, 14:5611-21. 10.19102\/icrm.2023.14101","journal-title":"J Innov Card Rhythm Manag"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S345576","article-title":"The impact of the duration of cardiac troponin I elevation on the clinical prognosis as well as incidence of new-onset atrial fibrillation respectively in elderly non-ST-elevation acute myocardial infarction patients without PCI","volume":"14","author":"Wang Y","year":"2021","unstructured":"Wang Y, Wang XD, Yao JW, et al.. The impact of the duration of cardiac troponin I elevation on the clinical prognosis as well as incidence of new-onset atrial fibrillation respectively in elderly non-ST-elevation acute myocardial infarction patients without PCI. J Inflamm Res. 2021, 14:6907-16. 10.2147\/JIR.S345576","journal-title":"J Inflamm Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.15406\/jccr.2018.11.00364","article-title":"A review of cardiac and non-cardiac causes of troponin elevation and clinical relevance part II non cardiac causes","volume":"11","author":"Akwe J","year":"2018","unstructured":"Akwe J, Halford B, Kim E, Miller A. A review of cardiac and non-cardiac causes of troponin elevation and clinical relevance part II non cardiac causes. J Cardiol Curr Res. 2018, 11:00364. 10.15406\/jccr.2018.11.00364","journal-title":"J Cardiol Curr Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s43678-021-00167-y","article-title":"2021 CAEP acute atrial fibrillation\/flutter best practices checklist","volume":"23","author":"Stiell IG","year":"2021","unstructured":"Stiell IG, de Wit K, Scheuermeyer FX, et al.. 2021 CAEP acute atrial fibrillation\/flutter best practices checklist. CJEM. 2021, 23:604-10. 10.1007\/s43678-021-00167-y","journal-title":"CJEM"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint\u00a0Committee\u00a0on\u00a0Clinical Practice Guidelines","volume":"83","author":"Joglar JA","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al.. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint\u00a0Committee\u00a0on\u00a0Clinical Practice Guidelines. J Am Coll Cardiol. 2024, 83:109-279. 10.1016\/j.jacc.2023.08.017","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2024.06.003","article-title":"Optimizing energy delivery in cardioversion: a randomized PROTOCOLENERGY trial of 2 different algorithms in patients with atrial fibrillation. [IN PRESS]","author":"Roman M","year":"2024","unstructured":"Roman M, Lucjan R, Otakar J, et al.. Optimizing energy delivery in cardioversion: a randomized PROTOCOLENERGY trial of 2 different algorithms in patients with atrial fibrillation. [IN PRESS]. Can J Cardiol. 2024, 10.1016\/j.cjca.2024.06.003","journal-title":"Can J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.hroo.2022.12.004","article-title":"Absence of significant myocardial injury following elective direct current cardioversion for atrial fibrillation","volume":"4","author":"Lobo R","year":"2023","unstructured":"Lobo R, White RD, Donato LJ, Wockenfus AM, Kelley BR, Melduni RM, Jaffe AS. Absence of significant myocardial injury following elective direct current cardioversion for atrial fibrillation. Heart Rhythm O2. 2023, 4:180-6. 10.1016\/j.hroo.2022.12.004","journal-title":"Heart Rhythm O2"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.22541\/au.158757997.70129388","article-title":"The characterization of troponin I levels post synchronised direct-current cardioversion in patients with atrial arrhythmias","author":"Sless R","year":"2020","unstructured":"Sless R, Allen G, Hayward N, Fahy G. The characterization of troponin I levels post synchronised direct-current cardioversion in patients with atrial arrhythmias. Authorea. 2020, 10.22541\/au.158757997.70129388","journal-title":"Authorea"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2005.00038.x","article-title":"Serum troponin I and myoglobin after monophasic versus biphasic transthoracic shocks for cardioversion of persistent atrial fibrillation","volume":"28","author":"Kosior DA","year":"2005","unstructured":"Kosior DA, Opolski G, Tadeusiak W, et al.. Serum troponin I and myoglobin after monophasic versus biphasic transthoracic shocks for cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol. 2005, 28:S128-32. 10.1111\/j.1540-8159.2005.00038.x","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960281005","article-title":"Serum troponin I level after external electrical direct current synchronized cardioversion in patients with normal or reduced ejection fraction: no evidence of myocytes injury","volume":"28","author":"Cemin R","year":"2005","unstructured":"Cemin R, Rauhe W, Marini M, Pescoller F, Pitscheider W. Serum troponin I level after external electrical direct current synchronized cardioversion in patients with normal or reduced ejection fraction: no evidence of myocytes injury. Clin Cardiol. 2005, 28:467-70. 10.1002\/clc.4960281005","journal-title":"Clin Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.10.009","article-title":"Significance of high-sensitivity troponin T after elective external direct current cardioversion for atrial fibrillation or atrial flutter","volume":"121","author":"Lobo R","year":"2018","unstructured":"Lobo R, Jaffe AS, Cahill C, et al.. Significance of high-sensitivity troponin T after elective external direct current cardioversion for atrial fibrillation or atrial flutter. Am J Cardiol. 2018, 121:188-92. 10.1016\/j.amjcard.2017.10.009","journal-title":"Am J Cardiol"},{"key":"ref24","unstructured":"Medscape. Synchronized electrical cardioversion. (2018). https.\/\/emedicine.medscape.com\/article\/1834044-overview?form=fpf."},{"key":"ref25","article-title":"Myoglobin and troponin I as markers of myocardial damage during cardioversion of atrial fibrillation. (Article in Polish)","volume":"110","author":"Kosior D","year":"2003","unstructured":"Kosior D, Chwyczko T, Stawicki S, Tadeusiak W, Rabczenko D, Opolski G. Myoglobin and troponin I as markers of myocardial damage during cardioversion of atrial fibrillation. (Article in Polish). Pol Arch Med Wewn. 2003, 110:827-36.","journal-title":"Pol Arch Med Wewn"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2019.0310","article-title":"Efficacy and safety of outpatient clinic-based elective external electrical cardioversion in patients with atrial fibrillation","volume":"50","author":"Son NK","year":"2020","unstructured":"Son NK, Park JW, Kim M, et al.. Efficacy and safety of outpatient clinic-based elective external electrical cardioversion in patients with atrial fibrillation. Korean Circ J. 2020, 50:511-23. 10.4070\/kcj.2019.0310","journal-title":"Korean Circ J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/270150-evaluation-of-changes-in-cardiac-troponin-i-levels-after-direct-current-cardioversion-in-patients-with-atrial-fibrillation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T06:54:02Z","timestamp":1724050442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/270150-evaluation-of-changes-in-cardiac-troponin-i-levels-after-direct-current-cardioversion-in-patients-with-atrial-fibrillation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,18]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.67162","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,18]]}}}